NeuroSense Therapeutics (NRSN) Return on Assets (2022 - 2025)
NeuroSense Therapeutics (NRSN) posted Return on Assets of 0.03% for Q4 2025, down 41.63% sequentially from 0.05% in Q2 2025, and down 1.0% YoY from 0.03% in Q4 2024.
NeuroSense Therapeutics (NRSN) Return on Assets (2022 - 2025) Analysis & Trends
NeuroSense Therapeutics has reported Return on Assets for 4 years, with the latest figure at 0.03% in Q4 2025.
- Quarterly Return on Assets fell 1.0% year-over-year to 0.03% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.03% (down 1.0% YoY) and the FY2025 annual result came in at 0.04%, up 1.0% from the prior year.
- Return on Assets retreated to 0.03% in Q4 2025 per NRSN's latest filing, from 0.05% in the prior quarter.
- Over five years, Return on Assets peaked at 0.05% in Q2 2025 and troughed at 0.08% in Q3 2024.
- A 4-year average of 0.0% and a median of 0.01% in 2022 frame the typical range for Return on Assets.
- The widest YoY moves for Return on Assets: up 6 bps in 2024, down 10 bps in 2024.
- Over 4 years, Return on Assets stood at 0.01% in 2022, then tumbled by 290 bps to 0.02% in 2023, then jumped by 256 bps to 0.04% in 2024, then fell by 21 bps to 0.03% in 2025.
- According to Business Quant data, Return on Assets over the past three periods registered 0.03%, 0.05%, and 0.04% for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | NeuroSense Therapeutics | 9.68 Mn | 9.47 Mn | - | -0.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.03% |
| Jun 30, 2025 | 0.05% |
| Dec 31, 2024 | 0.04% |
| Sep 30, 2024 | -0.08% |
| Jun 30, 2024 | 0.02% |
| Mar 31, 2024 | -0.05% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | 0.02% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.02% |
| Dec 31, 2022 | 0.01% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.01% |
| Mar 31, 2022 | 0.01% |